Dexcom Expands Time in Range Initiative with Nick Jonas to Help Improve the Lives of People with Diabetes in the UK
Time in range is a powerful metric for modern diabetes management - but a new survey finds less than half of people with insulin-treated diabetes are even using it.1
Visit Dexcom.com/InRange to learn more
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211013005048/en/
In fact, time in range is so crucial that over half (51%) of survey respondents said they would rather swim with sharks than go low during an important meeting or event. While technology exists to help keep track of glycemic control, many people in the
“Time in Range is about coming together and giving people with diabetes the tools and resources to help them feel healthier and live the life they want,” said multi-platinum recording artist, actor and philanthropist
Time in range also helps insulin-treated people with diabetes make informed treatment decisions instead of relying solely on the three-month average that a traditional A1C test provides. Other key survey1 findings include:
- The vast majority (83%) of people with insulin-treated diabetes say they feel better when they spend more time in range, yet two-thirds (59%) of people do not use time in range as a metric to gauge treatment success
- While the majority (77%) of people with insulin-treated diabetes also say they feel healthier when they spend more time in range, most (62%) say they do not talk about it regularly with their healthcare provider
- About two-thirds (66%) of people with insulin-treated diabetes surveyed said they agree it is the responsibility of their healthcare provider to bring new standards of care to their attention
- More than half (58%) of people with insulin-treated diabetes agree that if they were to spend more time in range, they’d feel more confident to pursue their dreams or passions
- Many respondents (68%) said that overall, they wish they had a better understanding of the available technologies to help manage diabetes
“There are such great tools out there today to measure time in range,” said
Though the majority (69%) of people with insulin-treated diabetes believe they deserve the most cutting-edge technology available to manage their disease, 1 access to CGM can vary significantly between clinical commissioning groups due to the UK’s postcode lottery system. In fact, around one-third of those using
To get further information about time in range and access to resources for people with diabetes as well as healthcare providers, visit www.Dexcom.com/InRange. Join the conversation on social media at #WhenInRange.
2Defined by the T1D Outcomes Programme and the International Consensus on Time in Range as 3.9 and 10.0 mmol/L (equivalent to 70-80 mg/dL and 180 mg/dL) at least 70% of the time. Each individual should consult their healthcare provider.
*For a list of complete devices, visit www.dexcom.com/en-GB/compatibility
+If your glucose alerts and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.